Article Text
Special communication
Reducing tobacco-related harm: FDA’s proposed product standard for smokeless tobacco
Abstract
This Special Communication discusses the Food and Drug Administration’s (FDA’s) proposed rule that would limit N-nitrosonornicotine (NNN) levels in smokeless tobacco products. It argues that finalising and implementing this first ’product standard' would mark a significant step forward in the FDA’s efforts to reduce tobacco-related harms.
- public policy
- Non-cigarette tobacco products
- harm reduction
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.